Clinical Trial Update: A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating NKT5097 in adults with advanced or metastatic solid tumors, including various breast cancer subtypes and gynecologic cancers. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Ovarian Cancer
• Solid Tumors with Ccne1 Amplification
• Triple-negative Breast Cancer
• Uterine Carcinosarcoma

Drugs mentioned

• NKT5097

Snippet

Sponsor: NiKang Therapeutics, Inc. | Conditions: HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC) | Phase 1 | Status: RECRUITING